Securin (hPTTG1) expression is regulated by β-catenin/TCF in human colorectal carcinoma

28Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Overexpression of the transcriptional activator β-catenin, mostly owing to loss-of-function mutations of the adenomatous polyposis coli (APC) tumour suppressor gene, is crucial for the initiation and progression of human colorectal carcinogenesis. Securin is a regulator of chromosome separation and its overexpression has been shown to be involved in different tumour-promoting processes, like transformation, hyperproliferation and angiogenesis, and correlates with tumour cell invasion. However, the molecular mechanism leading to securin overexpression in human colorectal cancer is unknown. Here we show a correlated high expression of β-catenin and securin (hPTTG1) in colorectal adenomas and carcinomas and further demonstrate that securin is a target of β-catenin transcriptional activation. This implies that deregulation of the β-catenin/T-cell factor-signalling pathway leads to overexpression of securin in human colorectal cancer, which subsequently may contribute to tumour progression. © 2006 Cancer Research UK.

Cite

CITATION STYLE

APA

Hlubek, F., Pfeiffer, S., Budczies, J., Spaderna, S., Jung, A., Kirchner, T., & Brabletz, T. (2006). Securin (hPTTG1) expression is regulated by β-catenin/TCF in human colorectal carcinoma. British Journal of Cancer, 94(11), 1672–1677. https://doi.org/10.1038/sj.bjc.6603155

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free